Hyperfine (HYPR) Cash & Equivalents (2020 - 2026)
Hyperfine (HYPR) posted Cash & Equivalents of $40.8 million for Q1 2026, up 16.23% on a QoQ basis from $35.1 million in Q4 2025, and up 23.22% year-over-year from $33.1 million in Q1 2025.
Hyperfine (HYPR) Cash & Equivalents (2020 - 2026) Analysis & Trends
Hyperfine's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $40.8 million for Q1 2026.
- Quarterly Cash & Equivalents rose 23.22% year-over-year to $40.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.8 million (up 23.22% YoY) and the FY2025 annual result came in at $35.1 million, down 6.8% from the prior year.
- Cash & Equivalents was $40.8 million for Q1 2026 at Hyperfine, up from $35.1 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $161.6 million in Q1 2022 and bottomed at $21.6 million in Q3 2025.
- A 5-year average of $74.8 million and a median of $63.2 million in 2024 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2022 — Cash & Equivalents soared 102.34% — and 2025, when it tumbled 52.88%.
- Hyperfine's Cash & Equivalents stood at $117.5 million in 2022, then sank by 36.0% to $75.2 million in 2023, then slumped by 49.93% to $37.6 million in 2024, then slipped by 6.8% to $35.1 million in 2025, then gained by 16.23% to $40.8 million in 2026.
- Business Quant data shows HYPR's Cash & Equivalents at $40.8 million in Q1 2026, $35.1 million in Q4 2025, and $21.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | 40.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.78 Mn |
| Dec 31, 2025 | 35.09 Mn |
| Sep 30, 2025 | 21.56 Mn |
| Jun 30, 2025 | 25.42 Mn |
| Mar 31, 2025 | 33.09 Mn |
| Dec 31, 2024 | 37.65 Mn |
| Sep 30, 2024 | 45.77 Mn |
| Jun 30, 2024 | 53.81 Mn |
| Mar 31, 2024 | 63.20 Mn |
| Dec 31, 2023 | 75.18 Mn |
| Sep 30, 2023 | 85.42 Mn |
| Jun 30, 2023 | 93.95 Mn |
| Mar 31, 2023 | 104.03 Mn |
| Dec 31, 2022 | 117.47 Mn |
| Sep 30, 2022 | 132.48 Mn |
| Jun 30, 2022 | 145.10 Mn |
| Mar 31, 2022 | 161.58 Mn |
| Dec 31, 2021 | 188.50 Mn |
| Sep 30, 2021 | 65.48 Mn |
| Jun 30, 2021 | 77.39 Mn |